The Patent Finder

Epitracker, Inc.

6 patents currently held · Updated Nov 19, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Oct 2038
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Oct 9, 2027
    The maintenance fee for Fatty Acid Analogs and Their Use in the Treatment of Conditions Related to Metabolic Syndrome (US 11,951,088) comes due Oct 9, 2027. Unpaid by Apr 10, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 6 of 6

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,792,266Fatty Acid Analogs and Their Use in the Treatment of Conditions Related to Metabolic Syndrome
In force
 · High confidence
In forceHigh confidence
US 11,951,088Fatty Acid Analogs and Their Use in the Treatment of Conditions Related to Metabolic Syndrome
In force
 · Medium confidence
In forceMedium confidence
US 11,992,473Compositions and Methods for Diagnosis and Treatment of Conditions Related to the Quality of Aging and Longevity
In force
 · Medium confidence
In forceMedium confidence
US 12,370,166Pentadecanoylcarnitine for treatment of conditions related to the quality of aging and longevity
In force
 · USPTO record
In forceUSPTO record
US 12,427,179Compositions and methods for diagnosis and treatment of neurodegenerative diseases
In force
 · USPTO record
In forceUSPTO record
US 12,440,473Fatty acid analogs and their use in the treatment of cognitive impairment, behavioral conditions, and chronic pain
In force
 · USPTO record
In forceUSPTO record

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

5 pending · 3 no status recorded

Showing 1 to 8 of 8, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
18/667,970Compositions and Methods for Diagnosis and Treatment of Conditions Related to the Quality of Aging and LongevityMay 17, 2024Pending
18/623,536Fatty Acid Analogs and Their Use in the Treatment of Conditions Related to Metabolic SyndromeApr 1, 2024Pending
18/447,059Aug 9, 2023No status recorded
18/309,998Compositions and Methods for Diagnosis and Treatment of Conditions Related to the Quality of Aging and LongevityMay 1, 2023Pending
18/170,379Feb 16, 2023No status recorded
18/168,382Compositions and Methods for Treatment of ObesityFeb 13, 2023Pending
17/380,622Compositions and Methods for Diagnosis and Treatment of Conditions Related to the Quality of Aging and LongevityJul 20, 2021Pending
17/086,198Oct 30, 2020No status recorded
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited